早期宫颈癌微创与开腹根治性子宫切除术不良事件发生率:随机对照试验结果
该多国随机非劣效性试验纳入631例早期宫颈癌患者,比较微创(n=319)与开腹(n=312)根治性子宫切除术的不良事件。分析536例患者,微创组与开腹组术中≥2级不良事件发生率分别为12%与10%,术后≥2级分别为54%与48%,差异均无统计学意义。结论认为两种术式不良事件总体发生率相似。
要点
- 微创组术中≥2级不良事件12%(34/279) vs 开腹组10%(26/257),差异2.1%(95%CI -3.3~7.4%,P=.45)。
- 微创组术后≥2级不良事件54%(152/279) vs 开腹组48%(124/257),差异6.2%(95%CI -2.2~14.7%,P=.14)。
- 两组术中及术后不良事件总体发生率相似,差异未达统计学显著。
核心结论
- 对于早期宫颈癌,与开腹根治性子宫切除术相比,微创根治性子宫切除术的术中或术后不良事件总体发生率相似。
研究设计与样本
- 腹腔镜宫颈癌根治术(LACC)试验为多国、随机、非劣效性试验,于2008年至2017年间开展。
- 来自24个国家33个三级妇科癌症中心的外科医生将631例国际妇产科联盟2009分期IA1伴淋巴血管浸润至IB1期宫颈癌女性随机分配至微创组(n=319)或开腹根治性子宫切除术组(n=312)。
- 该试验因微创手术组复发和死亡风险增加于2017年9月暂停入组;本文报告术后6个月内术中及术后不良事件发生率的次要结局指标。
- 631例随机分配患者中,536例(85%;平均年龄46.0岁)符合本分析纳入标准;279例(52%)接受微创根治性子宫切除术,257例(48%)接受开腹根治性子宫切除术。
主要发现
- 536例中,300例(56%)发生至少1次≥2级不良事件,91例(16.9%)发生≥3级不良事件,69例(12.8%)发生严重不良事件。
- 术中≥2级不良事件发生率:微创组12%(34/279) vs 开腹组10%(26/257);差异2.1%(95%CI -3.3~7.4%;P=.45)。
- 术后≥2级不良事件总体发生率:微创组54%(152/279) vs 开腹组48%(124/257);差异6.2%(95%CI -2.2~14.7%;P=.14)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective. OBJECTIVE: The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer. STUDY DESIGN: The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery. RESULTS: Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, -3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, -2.2 to 14.7%; P=.14). CONCLUSION: For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events.
引用
- Obermair A, Asher R, Pareja R, et al. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Am J Obstet Gynecol. 2019. PMID: 31586602. doi:10.1016/j.ajog.2019.09.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。